Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas induced COPD Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Effect of 2 weeks oral corticosteroids trial on gas exchange in mild stable asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 87s Year: 2003
The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020
The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients Source: Annual Congress 2006 - COPD therapy Year: 2006
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004
The effects of a crossover treatment with inhaled corticosteroids and N-acetylcysteine on lung function parameters in COPD-patients Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
Addition of theophylline to standard inhalatory therapy in patients with stable COPD: effects on exercise tolerance Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
The influence of high doses of N-acetylcysteine alone or in combination with inhaled corticosteroids on quality of life in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
The interrelationship of the inflammatory markers in blood and sputum of stable COPD patients before and after treatment with inhaled steroids and N-acetylcysteine Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD Source: Annual Congress 2010 - COPD: management Year: 2010
Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD Source: Annual Congress 2004 - Exercise and systemic effects in COPD Year: 2004
Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
When to give corticosteroid inhalation therapy in stable COPD Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001